Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Dacliximab

Base Information
  • Chemical Name:Dacliximab
  • CAS No.:152923-56-3
  • Molecular Formula:
  • Molecular Weight:0
  • Hs Code.:
Dacliximab

Synonyms:Dacliximab;Daclizumab; Immunoglobulin G 1 (human-mouse monoclonal clone 1H4 g-chain anti-human antigen Tac),disulfide with human-mouse monoclonal clone 1H4 light chain, dimer;Immunoglobulin G 1 (human-mouse monoclonal clone 1H4 g-chain anti-human interleukin 2receptor), disulfide with human-mouse monoclonal clone 1H4 light chain, dimer;Ro 24-7375; Zenapax

Suppliers and Price of Dacliximab
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • American Custom Chemicals Corporation
  • DACLIZUMAB 98.00%
  • 5G
  • $ 5370.75
  • American Custom Chemicals Corporation
  • DACLIZUMAB 98.00%
  • 1G
  • $ 2310.00
  • American Custom Chemicals Corporation
  • DACLIZUMAB 98.00%
  • 10MG
  • $ 745.85
Total 17 raw suppliers
Chemical Property of Dacliximab
Chemical Property:
  • PSA:0.00000 
  • LogP:0.00000 
Purity/Quality:

99% *data from raw suppliers

DACLIZUMAB 98.00% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:
Useful:
  • Uses Dacliximab is monoclonal antibody (immunosuppressant.
  • Clinical Use Molecularly, daclizumab (Zenapax, Chimeric) is an IgG1MAb that binds specifically to the α subunit of the IL-2 receptor(the complete, high-affinity activated IL-2 receptorconsists of interacting α, β, and γ subunits). IL-2 receptorsare expressed on the surfaces of activated lymphocytes,where they mediate lymphocyte clonal expansion and differentiation.Daclizumab is a chimeric protein (90% humanand 10% mouse) IgG1. The MAb targets only recently activatedT cells that have interacted with antigen and have developedfrom their naive form into their activated form. Itis at this time that the IL-2 receptors are expressed. Thehuman amino acid sequences of daclizumab derive fromconstant domains of human IgG, and the variable domainsare derived from the fused Eu myeloma antibody. Themurine sequences derive from CDRs of a mouse anti-IL2αantibody.The indications for daclizumab are prophylaxis of acuteorgan rejection in patients receiving renal transplants, aspart of an immunosuppressant regimen including cyclosporineand corticosteroids. The mechanism of action isthe same as that of basiliximab.
  • Drug interactions Potentially hazardous interactions with other drugsAvoid live vaccines.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 152923-56-3